Consistent with a potential oncogenic role, SKI and SnoN are often expressed at high levels in various human cancers cells derived from melanoma, esophageal cancer, pancreatic cancer and leukemia, due to increased transcription, gene amplification, and/or protein stabilization. This evidence concerns the gene SKI and leukemia.